ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) David Reardon, MD, director…
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) David Reardon, MD, director…
From mouthwatering results in one of the most talked-about pancreatic cancer papers of the year, through to Bob Marley’s melanoma, this episode unpacks the latest oncology papers. With thanks to our Host Craig Underhill, joined by Dr Kate Clarke and Professor Christopher Jackson…
Sleep deprivation has long been known to weaken the immune system. Now University of Florida…
Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced clinical…
A new review was published in Volume 17 of Oncotarget, titled Cancer without borders: Policy frameworks for…
Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral…
A large international cohort study published in JAMA Oncology adds further weight to the case…
A quality improvement randomised clinical trial published in JAMA Network Open has found that behaviourally…
A phase 3 randomised, double-blind trial published in The Lancet has evaluated the addition of…
From cholangiocarcinoma to chrono-oncology, this episode explores whether promising signals are ready to translate into meaningful patient benefit. With thanks to our Host Craig Underhill, joined by Dr Kate Clarke and Professor Christopher Jackson…